Draig Therapeutics
PrivateLast Round
Series B
Jul 14, 2026
Total Funding Raised
$205M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Draig Therapeutics is a biotechnology company that develops small molecule therapies for neuropsychiatric disorders, including major depressive disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Draig Therapeutics Comparables
Compare Draig Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Catalent | 65% | |
| Evonik Industries AG | 65% | |
| Implexis | 64% |
Draig Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 14, 2026 | ||||
| Series A | Jun 18, 2025 | ||||
| Seed | Sep 1, 2024 |
Key People
Founding team and executive leadership
Draig Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B |
| SV Health Investors | Series A, Seed |
| Intermediate Capital Group | Series A |
| British Business Bank | Series B |
| Deep Track Capital | Series B |
| Jefferson Life Sciences | Series B |
| Canaan Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 64% MoM, reaching 1.7K.
- Jul 14, 2026
$65M round led by Deep Track Capital.
Draig Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Draig Therapeutics's valuation, stock price, and market status.
Is Draig Therapeutics a public or private company?
Draig Therapeutics is a private company.
What is the current stock price of Draig Therapeutics?
Draig Therapeutics is a private company, so its shares have no public market price. Caplight tracks Draig Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Draig Therapeutics worth (valuation)?
Valuation information for Draig Therapeutics is not publicly available.
Can I buy Draig Therapeutics stock?
Draig Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Draig Therapeutics's last funding round?
Draig Therapeutics's most recent funding round was Series B on July 14, 2026.
Who are the main investors in Draig Therapeutics?
Key investors in Draig Therapeutics include SV Health Investors, Deep Track Capital, Access Biotechnology.
Will Draig Therapeutics IPO soon?
No public IPO plans have been announced for Draig Therapeutics.
How can I track Draig Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Draig Therapeutics's shares on secondary markets.